[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342214-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342214-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-large-scale-proteomics-resource-of-circulating-extracellular-vesicles-for-biomarker-discovery-in-pancreatic-cancer-elife-assessment","A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer - eLife Assessment","","A large-scale proteomics study analyzes human plasma samples to identify protein signatures carried by circulating extracellular vesicles (cEVs) for early diagnosis of pancreatic cancer. Using the EVtrap method for efficient EV isolation, researchers perform proteomics on samples from 124 individuals, including pancreatic ductal adenocarcinoma (PDAC), benign pancreatic diseases, and controls. EV proteins linked to PDAC and clinical features, including metastasis and poor prognosis, are identified and validated, culminating in a seven-protein EV PDAC signature with high diagnostic prediction accuracy. The work provides evidence supporting EV-based biomarkers and an open-source proteomic atlas for the research community.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-large-scale-proteomics-resource-of-circulating-extracellular-vesicles-for-biomarker-discovery-in-pancreatic-cancer-elife-assessment/342214/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-large-scale-proteomics-resource-of-circulating-extracellular-vesicles-for-biomarker-discovery-in-pancreatic-cancer-elife-assessment/342214.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address for pancreatic cancer diagnosis?","Question",{"text":63,"@type":64},"The study targets the urgent need for reliable biomarkers because pancreatic cancer is often diagnosed late and existing serologic biomarkers have limited performance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were extracellular vesicles (EVs) isolated and analyzed?",{"text":68,"@type":64},"The researchers used the EVtrap method to efficiently isolate EVs from plasma, followed by proteomics profiling of samples from PDAC patients, benign disease patients, and controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What biomarkers or protein signatures were reported for PDAC detection and clinical relevance?",{"text":72,"@type":64},"EV proteins such as PDCD6IP, SERPINA12, and RUVBL2 were associated with PDAC, metastasis-associated proteins were identified, and a seven-EV-protein PDAC signature was validated with an 89% prediction accuracy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342214,1790158694,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TOOLS AND ReSOURCeS  \n*For correspondence:  \nanton.iliuk@tymora-analytical. com (AI); [senthil.muthuswamy@nih.gov](senthil.muthuswamy@nih.gov)[ ](senthil.muthuswamy@nih.gov)(SKM)  \n†These authors contributed equally to this work  \nCompeting interest: See page 13  \nFunding: See page 14  \nSent for Review  \n13 March 2023  \nPreprint posted  \n20 March 2023  \nReviewed preprint posted  \n03 July 2023  \nReviewed preprint revised  \n24 October 2024  \nVersion of Record published  \n18 December 2024  \nReviewing Editor: Wadih Arap, Rutgers, The State University of New Jersey, United States  \n This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nA large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer  \nBruno Bockorny1,2†, Lakshmi Muthuswamy3†, Ling Huang4†, Marco Hadisurya5, Christine Maria Lim6, Leo L Tsai2,7, Ritu R Gill2,7, Jesse L Wei2,7, Andrea J Bullock1,2, Joseph E Grossman8, Robert J Besaw1, Supraja Narasimhan9, Weiguo Andy Tao5, Sofia Perea1, Mandeep S Sawhney2,10, Steven D Freedman2,10, Manuel Hildago11,12†, Anton Iliuk13*†, Senthil K Muthuswamy14*†  \n1 Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, United States; 2 Harvard Medical School, Boston, United States; 3 Blueprint Medicines, Cambridge, United States; 4 Henry Ford Cancer Institute, Detroit, United States; 5 Department of Biochemistry, Purdue University West Lafayette, West Lafayette, United States; 6 Nanyang Technological University, Singapore, Singapore; 7 Department of Radiology, Beth Israel Deaconess Medical Center, Boston, United States; 8Agenus Inc, Lexington, United States; 9 Deciphera Pharmaceuticals, Waltham, United States; 10 Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, United States; 11 Division of Hematology-Oncology, Weill Cornell Medical College, New York, United States; 12 New York-Presbyterian Hospital, New York, United States; 13Tymora Analytical Operations, West Lafayette, United States; 14 National Cancer Institute, Bethesda, United States  \neLife Assessment  \nThe authors analyze a comprehensive cohort of human plasma samples to identify an extracellular vesicles protein signature for early diagnosis of pancreatic cancer. The application of liquid biopsies is valuable, and the work addresses a key clinical problem as pancreas cancer is often diagnosed in late stages. The strength of evidence is solid. Altogether, this work supports the potential use of extracellular vesicles in clinical settings, with promising value to scientists and clinicians.  \nAbstract Pancreatic cancer has the worst prognosis of all common tumors. Earlier cancer diagnosis could increase survival rates and better assessment of metastatic disease could improve patient care. As such, there is an urgent need to develop biomarkers to diagnose this deadly malignancy. Analyzing circulating extracellular vesicles (cEVs) using ‘liquid biopsies’ offers an attractive approach to diagnose and monitor disease status. However, it is important to differentiate EV-associated proteins enriched in patients with pancreatic ductal adenocarcinoma (PDAC) from those with benign pancreatic diseases such as chronic pancreatitis and intraductal papillary mucinous neoplasm (IPMN) . To meet this need, we combined the novel EVtrap method for highly efficient isolation of EVs from plasma and conducted proteomics analysis of samples from 124 individuals, including patients with PDAC, benign pancreatic diseases and controls. On average, 912 EV proteins were identified per 100 µL of plasma. EVs containing high levels of PDCD6IP, SERPINA12, and RUVBL2 were associated with PDAC compared to the benign diseases in both discovery and validation cohorts. EVs with PSMB4, RUVBL2, and ANKAR w","cbCaiaTxtMpIlojb","https://ap.wps.com/l/cbCaiaTxtMpIlojb","pdf",1551465,17,"English","# eLife Assessment\n## Abstract\n## Introduction","[{\"question\":\"What problem does the study address for pancreatic cancer diagnosis?\",\"answer\":\"The study targets the urgent need for reliable biomarkers because pancreatic cancer is often diagnosed late and existing serologic biomarkers have limited performance.\"},{\"question\":\"How were extracellular vesicles (EVs) isolated and analyzed?\",\"answer\":\"The researchers used the EVtrap method to efficiently isolate EVs from plasma, followed by proteomics profiling of samples from PDAC patients, benign disease patients, and controls.\"},{\"question\":\"What biomarkers or protein signatures were reported for PDAC detection and clinical relevance?\",\"answer\":\"EV proteins such as PDCD6IP, SERPINA12, and RUVBL2 were associated with PDAC, metastasis-associated proteins were identified, and a seven-EV-protein PDAC signature was validated with an 89% prediction accuracy.\"}]","A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer - eLife Assessment | PDF",1790045812,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/970e96e3960ed0cd69f463a76da217f1.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44d0e7015c2722d3c30eb20d943efc3f.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e6e47976a8fae3073a1bb9f9789bd6c.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2d861e1e5b0494b7feab81dcebe0e94.webp",980,1268]